AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...
Arabian Post on MSN4 天
AIM Vaccine mRNA RSV Vaccine Submits for Clinical Trials in the U.S.Multiple Institutions Give AIM a “Buy” RatingHONG KONG SAR – Media OutReach Newswire – 5 February 2025 – AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, announced today that its ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈